Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-24-002998
Accepted
2024-09-30 00:15:16
Documents
1
Effectiveness Date
2024-09-27
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 603
  Complete submission text file 9999999995-24-002998.txt   2122
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

EIN.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-282172 | Film No.: 241336405
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)